Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ZDX
|
|||
| Drug Name |
SM-88
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10; ICD-9: 157] | Phase 2/3 | [1] | |
| Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 2 | [2] | ||
| Company |
Tyme Technologies New York, NY
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H13NO3
|
|||
| Canonical SMILES |
CC(CC1=CC=C(C=C1)O)(C(=O)O)N
|
|||
| InChI |
1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)
|
|||
| InChIKey |
NHTGHBARYWONDQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 658-48-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Free radical (FRD) | Target Info | Stimulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03512756) A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.